相关实验视频

Updated: Jul 16, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

利用转录组信号用于肌缩侧面硬化症,以识别新型药物并增强风险预测

Oliver Pain¹, Ashley Jones¹, Ahmad Al Khleifat¹

¹Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

|August 22, 2024

概括

这项研究整合了遗传数据,揭示了对肌缩性侧面硬化症 (ALS) 原因和潜在治疗方法的新见解. 它确定了基因和药物,改善了对ALS风险和临床特征的预测.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
药理学药理学是指药理学的学科.

背景情况:

肌缩侧面硬化症 (ALS) 是一种具有复杂遗传基础的致命神经退行性疾病.
了解ALS的遗传结构对于开发有效的治疗方法至关重要.
目前对ALS遗传风险位点及其功能影响的了解需要进一步阐明.

研究的目的:

将全基因组关联研究 (GWAS) 数据与功能基因组学相结合,以获得对ALS的机械洞察力.
为了确定潜在的药物重用机会来治疗ALS.
为了提高ALS风险和临床特征的预测,使用多转录组分数.

主要方法:

在ALS GWAS总结统计数据上利用了基于SNP的精细映射 (SuSiE),全转录组关联研究 (TWAS) 和全蛋白组关联研究 (PWAS).
与DrugTargetor数据库集成的基因关联,用于药物重定向分析.
从TWAS基因关联计算的多转录组分数和外部ALS队列中观察到的血液表达.

主要成果:

确定了118个与ALS相关的基因,其中TWAS和PWAS提供了新的机制性见解.
发现六种与ALS相关基因相互作用的药物;确定通道阻断剂的潜在益处和抗药物的风险.
使用多转录组分数显著预测ALS风险 (R2=5.1%) 和临床特征.

结论:

对ALS GWAS数据的功能信息分析为疾病病因学提供了新的机制性见解.
突出了潜在的治疗研究途径,包括药物的重新用途.
实现了对ALS风险和临床特征的统计学显著预测,为个性化医学方法铺平了道路.

更多相关视频

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...